跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ASMALIN SYRUP 1.5 MG/5 ML - HSA Drug Approval Details
Approvals
/
HSA
/
ASMALIN SYRUP 1.5 MG/5 ML
Approved
THERAPEUTIC
ASMALIN SYRUP 1.5 MG/5 ML
SUNWARD PHARMACEUTICAL PRIVATE LIMITED - SINGAPORESUNWARD PHARMACEUTICAL SDN BHD (MALAYSIA)
🇸🇬 Health Sciences Authority
Approval Date
Jun 12, 1992
Approval ID
afc2d4120be7036f
Company
SUNWARD PHARMACEUTICAL PRIVATE LIMITED - SINGAPORESUNWARD PHARMACEUTICAL SDN BHD (MALAYSIA)
Type
Therapeutic
Approval Details
Approval Id
afc2d4120be7036f
Drug Name
ASMALIN SYRUP 1.5 MG/5 ML
Product Name
ASMALIN SYRUP 1.5 MG/5 ML
Approval Number
SIN07055P
Approval Date
1992-06-12
Registrant
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence Holder
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
PHARMACY ONLY MEDICINES
Dosage Form
SYRUP
Route Of Administration
ORAL
Atc Code
R03CC03
Atc Item Name
terbutaline
Pharma Manufacturer Name
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Active Ingredients
TERBUTALINE SULPHATE
1.5 mg/5 ml
TERBUTALINE SULPHATE
1.5 mg/5 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 12, 1992
Approval ID
afc2d4120be7036f
Type
Therapeutic
Back to HSA Approvals